Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

With the emergence and long-term Impact of COVID-19, Global Dermatophytic Onychomycosis Treatment Market to reach USD 8.66 Billion by 2030

Bizwit Research & Consulting LLP’s Recent Analysis on Global Dermatophytic Onychomycosis Treatment Market is poised to raise up to USD 8.66 Billion by 2030. Dermatophytic onychomycosis, also known as fungal nail infection, is a common condition caused by various types of fungi, primarily dermatophytes. It affects the nails, causing them to become discolored, brittle, and thickened. It constitutes approximately one-third of all fungal infections worldwide, with dermatophytes responsible for around 70%-80% of these cases. This growing prevalence has led to a rising need for medications designed to treat dermatophytic onychomycosis.

The growing cases of diabetes, increasing awareness of dermatophytic onychomycosis treatment, as well as surging demand for topical treatments are the most prominent factors that are propelling the market demand across the globe. Moreover, the increasing government support for research and development, as well as the rising introduction of new and innovative treatments presents various lucrative opportunities over the forecast years. However, the high cost of treatment and the side effects of treatment are hindering the market growth throughout the forecast period of 2023-2030.

Geographically, the global Dermatophytic Onychomycosis Treatment market has been segmented into North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa (MEA). North America dominated the market in 2022 owing to the growing investment in R&D activities, the introduction of generic versions of oral antifungal medications, along with the growing awareness about the impact of fungal nail infections. Whereas, Asia Pacific is expected to grow at the fastest CAGR over the forecast years. The rising healthcare expenditure, increasing prevalence of onychomycosis, and diabetic patient populations are significantly propelling the dermatophytic onychomycosis treatment market demand across the region.

The global Dermatophytic Onychomycosis Treatment market is highly competitive owing to the presence of several key market players such as Bausch Health Companies Inc., Pfizer Inc., Galderma S.A, GlaxoSmithKline plc, Janssen Pharmaceuticals, Inc., Cipla Inc., Kaken Pharmaceuticals Co., Ltd., and others.

For further analysis on this or to request a sample copy of this report, please click the link mentioned below:

Global Dermatophytic Onychomycosis Treatment Market Size Study & Forecast, by Product Type (Tablets, Nail Paints), By Route of Administration (Oral, Topical), By Type (Prescribed, Over-the-Counter (OTC)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channels), and Regional Analysis, 2023-2030

Key findings of the study suggest:

  • Global Dermatophytic Onychomycosis Treatment Market is anticipated to grow with a healthy growth rate of more than 8.0% over the forecast period 2023-2030.
  • In the Product Type segment, Tablets emerged out as the leading market segment in 2022.
  • North America is anticipated to drive regional growth owing to the growing investment in R&D activities, the introduction of generic versions of oral antifungal medications, along with the growing awareness about the impact of fungal nail infections.
  • Asia-Pacific is expected to grow at higher rate followed by North America during 2023-2030.

Bizwit Research & Consulting has considered following segments for the study:

  • Product Type:
  • Tablets
  • Nail Paints

Route of Administration:

  • Oral
  • Topical

Type:

  • Prescribed
  • Over-the-Counter (OTC)

Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Channels

Regional Outlook

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Korea
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

To get a sample of this report or to purchase a copy of the study, you can directly contact us at: sales@bizwitresearch.com

About Us

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. The company has a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. Bizwit incorporate big data, expert analysis, and huge industry database to deliver client focused business consulting reports. Our analysts perform unbiased measurement and assessment of market opportunities to comprehend detailed market forecast. Our team of key opinion leaders evaluates the market size, growth prospects, end-use, applications, value & supply chain and top vendors in the industry to help the clients to take conversant business decisions without any vague assumptions.

Contact US

Global Business Development

Phone : +1 209 498-3066

Email: Sales@bizwitresearch.com

Website: www.bizwitresearch.com

Leave a Reply

Your email address will not be published. Required fields are marked *